Dr. Akinyemi Oni-Orisan is a pharmacist-scientist and Assistant Professor at UCSF. The long-term research goal of Dr. Oni-Orisan’s lab is to improve pharmacological regimens for the prevention and treatment of cardiovascular disease in ancestrally diverse populations through precision medicine. To accomplish this objective, his group combines computational approaches in pharmacogenomics and pharmacoepidemiology using electronic health record-linked biorepositories. His lab is currently funded by the NIH to investigate genetic determinants of efficacy and safety for statin therapy in diverse populations. Dr. Oni-Orisan earned both his BS in biology (2006) and PharmD (2010) degrees at the University of Michigan. He received his PhD in Pharmaceutical Sciences (2015) from the Division of Pharmacotherapy and Experimental Therapeutics at the University of North Carolina. He completed a postdoctoral fellowship in the Clinical Pharmacology Training Program (2017) at the UCSF. He joined the faculty at UCSF in 2017.